<div class="container">

<table style="width: 100%;"><tr>
<td>carcinoma</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>Urothelial carcinoma.</h2>

<h3>Description</h3>

<p>Survival data from a trial comparing chemotherapy versus atezolizumab in the treatment of Urothelial carcinoma.
</p>


<h3>Usage</h3>

<pre><code class="language-R">data(carcinoma)
</code></pre>


<h3>Format</h3>

<p>A data frame with 625 observations (316 in the atezolizumab group and 309 chemotherapy group) with the following 3 columns:
</p>

<dl>
<dt>time</dt>
<dd>
<p>the observed follow-up times in days.</p>
</dd>
<dt>status</dt>
<dd>
<p>the event indicators, 0=right censored, 1= event.</p>
</dd>
<dt>group</dt>
<dd>
<p> the group labels, 1 = atezolizumab, 2 = chemotherapy.</p>
</dd>
</dl>
<h3>References</h3>

<p>Powles T, Dura?n I, van der Heijden MS, et al. Atezolizumab versus chemotherapy in patients with platinum-treated locally
advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial.
Lancet 2018; 391: 748-757.
</p>


</div>